About Birla Pharmaceuticals Private Limited
Data last updated:
Birla Pharmaceuticals Private Limited is a private limited company based in Sri Ganganagar, Rajasthan, India. It operates in the ayurvedic products and services segment of the healthcare sector. It was incorporated on 15 November 1990 and has been in existence for over 36 years.
The company is registered with the Registrar of Companies (ROC), Jaipur, under CIN U24232RJ1990PTC005678. Its GSTIN is 08AAACB6650L1ZI (Rajasthan).
The company has an authorised share capital of ₹5 Lakh and a paid-up capital of ₹1 Lakh. It is led by directors Naveen Kumar Birla and Santosh Kumar Birla.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at Birla Bhawan 46 Swami Dayanand Marg, Sri Ganganagar, Rajasthan, India – 335001.
As per the financials filed for FY 2024, the company reported a revenue of ₹61.48 Lakh, a growth of 13% compared to the previous year. For the same year it recorded a net profit of ₹72,044 (net margin 1.2%) and EBITDA of ₹1.3 Lakh (EBITDA margin 2.1%). Revenue has grown at a compounded annual rate (CAGR) of 19% over three years and 27% over five years.
Court records list 5 cases involving the company, including 1 filed against it; 3 cases are pending.
The current compliance status is marked as compliant by the Registrar of Companies. For more details, the company can be reached via its website birlapharmaceuticals.com.
- EmailLocked
- TelephoneLocked
- Website
- Social MediaLocked
- Registered AddressBirla Bhawan 46 Swami Dayanand Marg, Sri Ganganagar, Rajasthan, India – 335001
- IndustryHealthcare, Ayurvedic Products & Services
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
- One PDF report, delivered after checkout
Business Activity of Birla Pharmaceuticals Private Limited
The main business activity of Birla Pharmaceuticals is manufacturing. In detail, this covers chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products.
| Main Activity Group Code | Description of Main Activity | Business Activity Code | Description of Business Activity | Turnover Percentage |
|---|---|---|---|---|
| C | Manufacturing | C6 | Chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products | Locked |
Business activity turnover details
Turnover share and past changes in activity are in the company report.
- Turnover contribution
- Historical classifications
- Filing-level activity changes
Verified entity values are shown only after access is granted.
Financials of Birla Pharmaceuticals Private Limited FY 2025 filings available
Birla Pharmaceuticals Private Limited reported revenue of ₹61.48 Lakh (up 13% YoY) for FY 2024.
Compounded Annual Growth Rate (CAGR) of Birla Pharmaceuticals Private Limited
Revenue has grown at a compounded annual rate (CAGR) of 27% over five years, including 13% growth in the latest year. EBITDA rose 6% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary of Birla Pharmaceuticals Private Limited
| Metrics | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | •••• | •••• | •••• | •••• | •••• |
| Other Income | •••• | •••• | •••• | •••• | •••• |
| Total Revenue | •••• | •••• | •••• | •••• | •••• |
| Cost of Materials Consumed | •••• | •••• | •••• | •••• | •••• |
| Employee Benefit Expense | •••• | •••• | •••• | •••• | •••• |
| Finance Costs | •••• | •••• | •••• | •••• | •••• |
| Depreciation and Amortisation | •••• | •••• | •••• | •••• | •••• |
| Other Expenses | •••• | •••• | •••• | •••• | •••• |
| Total Expenses | •••• | •••• | •••• | •••• | •••• |
| EBITDA | ₹1.3 Lakh | •••• | •••• | •••• | •••• |
| Profit Before Tax | •••• | •••• | •••• | •••• | •••• |
| Tax Expense | •••• | •••• | •••• | •••• | •••• |
| Net Profit (PAT) | ₹72,044 | •••• | •••• | •••• | •••• |
| Balance Sheet | |||||
| Share Capital | •••• | •••• | •••• | •••• | •••• |
| Reserves and Surplus | •••• | •••• | •••• | •••• | •••• |
| Net Worth (Total Equity) | •••• | •••• | •••• | •••• | •••• |
| Long-term Borrowings | •••• | •••• | •••• | •••• | •••• |
| Short-term Borrowings | •••• | •••• | •••• | •••• | •••• |
| Trade Payables | •••• | •••• | •••• | •••• | •••• |
| Total Liabilities | •••• | •••• | •••• | •••• | •••• |
| Fixed Assets | •••• | •••• | •••• | •••• | •••• |
| Investments | •••• | •••• | •••• | •••• | •••• |
| Inventories | •••• | •••• | •••• | •••• | •••• |
| Trade Receivables | •••• | •••• | •••• | •••• | •••• |
| Cash and Bank Balance | •••• | •••• | •••• | •••• | •••• |
| Total Assets | •••• | •••• | •••• | •••• | •••• |
Financial Ratios of Birla Pharmaceuticals Private Limited
| Metrics | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 2.1% | •••• | •••• | •••• | •••• |
| Net Profit Margin | 1.2% | •••• | •••• | •••• | •••• |
| Return on Equity (ROE) | •••• | •••• | •••• | •••• | •••• |
| Return on Capital Employed (ROCE) | •••• | •••• | •••• | •••• | •••• |
| Return on Assets (ROA) | •••• | •••• | •••• | •••• | •••• |
| Liquidity and Debt | |||||
| Current Ratio | •••• | •••• | •••• | •••• | •••• |
| Quick Ratio | •••• | •••• | •••• | •••• | •••• |
| Debt-to-Equity Ratio | •••• | •••• | •••• | •••• | •••• |
| Interest Coverage Ratio | •••• | •••• | •••• | •••• | •••• |
| Efficiency and Growth | |||||
| Asset Turnover | •••• | •••• | •••• | •••• | •••• |
| Receivable Days | •••• | •••• | •••• | •••• | •••• |
| Payable Days | •••• | •••• | •••• | •••• | •••• |
| Inventory Days | •••• | •••• | •••• | •••• | •••• |
| Revenue Growth | •••• | •••• | •••• | •••• | •••• |
| Net Profit Growth | •••• | •••• | •••• | •••• | •••• |
Paid data: the figures shown as dots are available after purchase of the company report. Figures as filed with the MCA in Form AOC-4. The full year-wise statements and ratios of Birla Pharmaceuticals are in the company report.
Financial statements from 2015
Earlier years and trend charts are in the company report.
- Income statements
- Balance sheets
- Cash-flow statements
- Ratios and benchmarks
Verified entity values are shown only after access is granted.
Board of Directors of Birla Pharmaceuticals Private Limited
Birla Pharmaceuticals has 2 current directors and 2 former directors. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Naveen Kumar Birla | Director | 06 Mar 2012 | 14 Years 7 Months | Current |
| Santosh Kumar Birla | Director | 06 Mar 2012 | 14 Years 7 Months | Current |
Peer Comparison of Birla Pharmaceuticals Private Limited
Birla Pharmaceuticals Private Limited is compared with the companies closest to it by revenue in the Healthcare industry (Ayurvedic Products and Services, Pharmaceuticals). Net profit, margin and employee counts of each company are in the company report.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Anstiss Pharmaceuticals Private Limited | ₹61.9 Lakh (FY 2025) | •••• | •••• | 14.0% | •••• | Delhi, India |
| Suvrat Pharmaceuticals Private Limited | ₹61.87 Lakh (FY 2024) | •••• | •••• | 2846.0% | •••• | Thane, Maharashtra, India |
| Ayush Herbals & Naturals (OPC) Private Limited | ₹61.74 Lakh (FY 2024) | •••• | •••• | 147.0% | •••• | Secunderabad, Telangana, India |
| Altiva Pharmaceuticals (OPC) Private Limited | ₹61.74 Lakh (FY 2017) | •••• | •••• | 1156.0% | •••• | New Delhi, Delhi, India |
| Sunrun Pharmaceuticals Private Limited | ₹61.51 Lakh (FY 2024) | •••• | •••• | 50.0% | •••• | Bilaspur, Chhattisgarh, India |
| Birla Pharmaceuticals Private Limited this company | ₹61.48 Lakh (FY 2024) | •••• | •••• | 13.0% | •••• | Sri Ganganagar, Rajasthan, India |
| Shree Lokanath Pharmaceuticals Private Limited | ₹61.47 Lakh (FY 2025) | •••• | •••• | 41.0% | •••• | Aurangabad, Maharashtra, India |
| Pandit Agro Private Limited | ₹61.4 Lakh (FY 2025) | •••• | •••• | 12.0% | •••• | New Delhi, Delhi, India |
| Ayurera Research Laboratories (India) Private Limited | ₹61.34 Lakh (FY 2025) | •••• | •••• | 10.0% | •••• | Bareilly, Uttar Pradesh, India |
| Inhale Pharmaceuticals Private Limited | ₹61.33 Lakh (FY 2024) | •••• | •••• | 8.0% | •••• | Lucknow, Uttar Pradesh, India |
| Alois Pharmaceuticals Private Limited | ₹61.32 Lakh (FY 2025) | •••• | •••• | 34.0% | •••• | Kozhikode, Kerala, India |
Peers are the five companies nearest above and the five nearest below Birla Pharmaceuticals by revenue in the Healthcare industry (Ayurvedic Products and Services, Pharmaceuticals), from the latest filed financials of each company. Net profit, margin and employee counts of each peer are in the company report.
Auditor Details of Birla Pharmaceuticals Private Limited
Birla Pharmaceuticals Private Limited is audited by NIDHI CHITTLANGIA & ASSOCIATES for the financial year 2019.
| Name | Status | Appointment Date | Cessation Date |
|---|---|---|---|
| NIDHI CHITTLANGIA & ASSOCIATES | Locked | Locked | Locked |
Complete auditor history
Appointment and cessation dates and past auditor changes are in the company report.
- Appointment status
- Appointment dates
- Cessation dates
- Auditor changes
Verified entity values are shown only after access is granted.
Ownership and Shareholding of Birla Pharmaceuticals Private Limited
Shareholding and ownership data
Promoter, institutional, public and beneficial ownership figures are in the company report.
- Ownership categories
- Historical changes
- Group structure
- FII and DII holdings
Verified entity values are shown only after access is granted.
Charges & Borrowings of Birla Pharmaceuticals Private Limited
Birla Pharmaceuticals Private Limited does not have any charges (loans) registered with the Registrar of Companies.
Legal Cases of Birla Pharmaceuticals Private Limited
Birla Pharmaceuticals Private Limited has 5 court cases on record: 1 filed against it, 4 where it is another party. 3 cases are pending and 2 are disposed. Status as checked between 02 Oct 2026 and 04 Oct 2026.
Cases by court
| Court | Cases | Against the company | Pending |
|---|---|---|---|
| District courts | 5 | 1 | 3 |
Cases on record (5 of 5)
| Court | Type of case | Party | Status |
|---|---|---|---|
| District court, Satara, Maharashtra | Court case (R.C.C.) | Company is another party | Pending |
| District court, Mumbai CMM Courts, Maharashtra | Court case (Summons warrant cases SW) | Company is another party | Pending |
| District court, Jalna, Maharashtra | Court case (R.C.C.) | Company is another party | Pending |
| District court, Tonk, Rajasthan | Execution petition | Filed against the company by an individual | Disposed |
| District court, Dhule, Maharashtra | Court case (R.C.C.) | Company is another party | Disposed |
Full case history
All 5 cases with case numbers, court, year-wise trend, opposite parties and decision dates are in the company report.
- Every case with its case number
- Year-wise trend
- Opposite parties
- Decision dates and orders
Verified entity values are shown only after access is granted.
Case records are compiled from court listings and may lag the court's own records. A case filed against a company is not a finding against it.
Employees and EPFO Compliance at Birla Pharmaceuticals Private Limited
Employment history and EPFO contributions of people linked to Birla Pharmaceuticals.
Employee and EPFO history
Monthly headcount, contribution history and filing status are in the company report.
- Monthly headcount
- PF contributions
- ECR filing status
- Establishment history
Verified entity values are shown only after access is granted.
Recent Activity on Birla Pharmaceuticals Private Limited
Birla Pharmaceuticals Private Limited has 4 board changes on record since 2012: 2 appointments and 2 cessations. The latest: Praveen Birla ceased to be Director on 05 Apr 2012.
Credit Ratings, Litigation & Regulatory Alerts for Birla Pharmaceuticals Private Limited
Credit ratings, litigation, and regulatory alerts
Credit ratings, court records and regulatory alerts are in the company report.
- Rating history
- Court and tribunal cases
- Regulatory alerts
- Director-linked violations
Verified entity values are shown only after access is granted.
MSME Payment Delays by Birla Pharmaceuticals Private Limited
MSME payment history
Amounts due to small suppliers, the reasons given and MSME-1 filings are in the company report.
- Outstanding amounts
- Delay periods and reasons
- MSME-1 filing history
- Vendor payment signals
Verified entity values are shown only after access is granted.
Subsidiaries & Group Companies of Birla Pharmaceuticals Private Limited
Corporate group structure
Parent, subsidiary, associate and joint venture records with holdings are in the company report.
- Parent company
- Subsidiaries and ownership
- Associates and joint ventures
- Entity investments
Verified entity values are shown only after access is granted.
GST Compliance of Birla Pharmaceuticals Private Limited
Birla Pharmaceuticals has 1 GST registration: 1 active.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 08AAACB6650L1ZI | Rajasthan | Active | 01 Jul 2017 |
GST registrations and filing compliance
State-wise GST registrations, return filing status and HSN or SAC codes are in the company report.
- GSTIN registrations
- State-wise filing status
- HSN and SAC details
- Tax jurisdiction records
Verified entity values are shown only after access is granted.
MCA Filings & Documents of Birla Pharmaceuticals Private Limited
MCA filings and documents
Filed forms, annual returns, financial statements and charge filings with their dates are in the company report.
- Incorporation documents
- Annual returns and statements
- Charge filings
- Complete filing index
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Birla Pharmaceuticals Private Limited
Birla Pharmaceuticals is an active private limited company based in Sri Ganganagar, Rajasthan, India. The company works in ayurvedic products and services, within the healthcare industry. It was incorporated on 15 November 1990 (36+ years old) and is registered under CIN U24232RJ1990PTC005678.
Birla Pharmaceuticals reported revenue of ₹61.48 Lakh for FY 2024 (up 13% YoY).
Birla Pharmaceuticals has 2 current directors:
- Naveen Kumar Birla - Director
- Santosh Kumar Birla - Director
Birla Pharmaceuticals reported a net profit of ₹72,044 (net margin 1.2%) and EBITDA of ₹1.3 Lakh (EBITDA margin 2.1%) for FY 2024, as per its filed financial statements.
The compounded annual growth rate (CAGR) of the revenue of Birla Pharmaceuticals is 19% over three years and 27% over five years. In the latest year (FY 2024) revenue rose 13%. CAGR is the steady yearly rate that links the first and the last year.
The GSTIN of Birla Pharmaceuticals is 08AAACB6650L1ZI, registered in Rajasthan.
The CIN (Corporate Identification Number) of Birla Pharmaceuticals is U24232RJ1990PTC005678. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Birla Pharmaceuticals has 5 court cases on record: 1 filed against it. 3 are pending.
Birla Pharmaceuticals was incorporated on 15 November 1990, making it 36+ years old. It is registered with the Registrar of Companies, Jaipur.
The peers of Birla Pharmaceuticals by revenue are Anstiss Pharmaceuticals Private Limited, Suvrat Pharmaceuticals Private Limited, Ayush Herbals & Naturals (OPC) Private Limited, Altiva Pharmaceuticals (OPC) Private Limited, Sunrun Pharmaceuticals Private Limited and 5 more, all in the Healthcare industry (Ayurvedic Products and Services, Pharmaceuticals).
Praveen Birla ceased to be Director on 05 Apr 2012. Shital Birla ceased to be Director on 05 Apr 2012. Naveen Kumar Birla was appointed as Director on 06 Mar 2012. Birla Pharmaceuticals has 4 board changes on record in total.